T1	Participants 97 150	childhood ALL randomised trials, UKALL X and UKALL XI
T2	Participants 276 432	childhood acute lymphoblastic leukaemia (UKALL X) randomised patients aged 0-14 years inclusive with an initial white blood count of less than 100 x 10(9)/l
T3	Participants 540 578	UKALL XI, for children aged 1-14 years
